Profile of:

Suzanne Arends


Suzanne Arends is a clinical epidemiologist and biomedical scientist with main interest in clinical/translational research on disease activity, disease outcome and effect of treatment in RMDs (including axial SpA). Together with Anneke Spoorenberg, she is coordinator of the Groningen Leeuwarden Axial Spondyloarthritis (GLAS) cohort, a large prospective observational cohort to gain more knowledge about the long-term course of the disease during treatment in daily clinical practice.

Full name: Suzanne Arends

Current country: Netherlands

Membership level: Full

Type of membership: Member

Number of publications: 32

Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis (2021)
https://pubmed.ncbi.nlm.nih.gov/32530102/

High prevalence of hip involvement and decrease in inflammatory ultrasound lesions during tumour necrosis factor-α blocking therapy in ankylosing spondylitis (2019)
https://pubmed.ncbi.nlm.nih.gov/30624693/

High prevalence of clinical spondyloarthritis features in patients with hidradenitis suppurativa (2019)
https://pubmed.ncbi.nlm.nih.gov/30554892/

Although female patients with ankylosing spondylitis score worse on disease activity than male patients and improvement in disease activity is comparable, male patients show more radiographic progression during treatment with TNF-α inhibitors (2019)
https://pubmed.ncbi.nlm.nih.gov/30253878/

High prevalence of hidradenitis suppurativa symptoms in axial spondyloarthritis patients: A possible new extra-articular manifestation (2019)
https://pubmed.ncbi.nlm.nih.gov/29751976/

Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life (2018)
https://pubmed.ncbi.nlm.nih.gov/30487997/

Ankylosing spondylitis disease activity score is related to NSAID use, especially in patients treated with TNF-α inhibitors (2018)
https://pubmed.ncbi.nlm.nih.gov/29689112/

Social Role Participation and Satisfaction With Life: A Study Among Patients With Ankylosing Spondylitis and Population Controls (2018)
https://pubmed.ncbi.nlm.nih.gov/28622457/

Ankylosing spondylitis patients at risk of poor radiographic outcome show diminishing spinal radiographic progression during long-term treatment with TNF-α inhibitors (2017)
https://pubmed.ncbi.nlm.nih.gov/28640818/

Incorporating assessment of the cervical facet joints in the modified Stoke ankylosing spondylitis spine score is of additional value in the evaluation of spinal radiographic outcome in ankylosing spondylitis (2017)
https://pubmed.ncbi.nlm.nih.gov/28441960/

Ultrasound Evaluation of the Entheses in Daily Clinical Practice during Tumor Necrosis Factor-α Blocking Therapy in Patients with Ankylosing Spondylitis (2017)
https://pubmed.ncbi.nlm.nih.gov/28298566/

Radiographic damage and progression of the cervical spine in ankylosing spondylitis patients treated with TNF-α inhibitors: Facet joints vs. vertebral bodies (2017)
https://pubmed.ncbi.nlm.nih.gov/28040243/

Long-term drug survival and clinical effectiveness of etanercept treatment in patients with ankylosing spondylitis in daily clinical practice (2017)
https://pubmed.ncbi.nlm.nih.gov/27749222/

Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors (2017)
https://pubmed.ncbi.nlm.nih.gov/27696754/

Clinical Risk Factors for the Presence and Development of Vertebral Fractures in Patients With Ankylosing Spondylitis (2017)
https://pubmed.ncbi.nlm.nih.gov/27389998/

Social Role Participation in Patients With Ankylosing Spondylitis: A Cross-Sectional Comparison With Population Controls (2016)
https://pubmed.ncbi.nlm.nih.gov/27059161/

Radiographic vertebral fractures develop in patients with ankylosing spondylitis during 4 years of TNF-α blocking therapy (2016)
https://pubmed.ncbi.nlm.nih.gov/26886385/

Social Role Participation Questionnaire for patients with ankylosing spondylitis: translation into Dutch, reliability and construct validity (2016)
https://pubmed.ncbi.nlm.nih.gov/26870393/

Obesity Is Common in Axial Spondyloarthritis and Is Associated with Poor Clinical Outcome (2015)
https://pubmed.ncbi.nlm.nih.gov/26669924/

Accelerometer Quantification of Physical Activity and Activity Patterns in Patients with Ankylosing Spondylitis and Population Controls (2015)
https://pubmed.ncbi.nlm.nih.gov/26523021/

Male and female patients with axial spondyloarthritis experience disease activity, physical function and quality of life differently: results from the Groningen Leeuwarden Axial Spondyloarthritis cohort (2015)
https://pubmed.ncbi.nlm.nih.gov/25936792/

Spinal radiographic progression in patients with ankylosing spondylitis treated with TNF-α blocking therapy: a prospective longitudinal observational cohort study (2015)
https://pubmed.ncbi.nlm.nih.gov/25879956/

Higher bone turnover is related to spinal radiographic damage and low bone mineral density in ankylosing spondylitis patients with active disease: a cross-sectional analysis (2014)
https://pubmed.ncbi.nlm.nih.gov/24918782/

Clinical studies on bone-related outcome and the effect of TNF-α blocking therapy in ankylosing spondylitis (2014)
https://pubmed.ncbi.nlm.nih.gov/24625371/

Daily physical activity in ankylosing spondylitis: validity and reliability of the IPAQ and SQUASH and the relation with clinical assessments (2013)
https://pubmed.ncbi.nlm.nih.gov/23971767/

Validity and reliability of the Dutch adaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) Questionnaire (2013)
https://pubmed.ncbi.nlm.nih.gov/23418474/

The effect of three years of TNFα blocking therapy on markers of bone turnover and their predictive value for treatment discontinuation in patients with ankylosing spondylitis: a prospective longitudinal observational cohort study (2012)
https://pubmed.ncbi.nlm.nih.gov/22546520/

Baseline predictors of response to TNF-α blocking therapy in ankylosing spondylitis (2012)
https://pubmed.ncbi.nlm.nih.gov/22418743/

Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study (2011)
https://pubmed.ncbi.nlm.nih.gov/21689401/

Serum MMP-3 level as a biomarker for monitoring and predicting response to etanercept treatment in ankylosing spondylitis (2011)
https://pubmed.ncbi.nlm.nih.gov/21632677/

The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis (2011)
https://pubmed.ncbi.nlm.nih.gov/20603707/

The formation of autoantibodies and antibodies to TNF-α blocking agents in relation to clinical response in patients with ankylosing spondylitis (2010)
https://pubmed.ncbi.nlm.nih.gov/20822711/